These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31918399)

  • 1. New antifungal ent-labdane diterpenes against Candida glabrata produced by microbial transformation of ent-polyalthic acid.
    Pontes de Sousa I; Ferreira AG; Miller Crotti AE; Alves Dos Santos R; Kiermaier J; Kraus B; Heilmann J; Jacometti Cardoso Furtado NA
    Bioorg Chem; 2020 Jan; 95():103560. PubMed ID: 31918399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of More Potent Anti-Candida Labdane Diterpenes by Biotransformation Using Cunninghamella elegans.
    Sousa IP; De Sousa Teixeira MV; Freitas JA; Ferreira AG; Pires LM; Santos RA; Heleno VCG; Furtado NAJC
    Chem Biodivers; 2022 Mar; 19(3):e202100757. PubMed ID: 35092349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ent-hardwickiic acid from C. pubiflora and its microbial metabolites are more potent than fluconazole in vitro against Candida glabrata.
    Sousa Teixeira MV; Fernandes LM; Stefanelli de Paula V; Ferreira AG; Jacometti Cardoso Furtado NA
    Lett Appl Microbiol; 2022 Apr; 74(4):622-629. PubMed ID: 34995375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of new ent-hardwickiic acid derivatives by microbial transformation and their antifungal activity.
    Teixeira MVS; Fernandes LM; de Paula VS; Ferreira AG; Pires LM; Santos RA; Furtado NAJC
    Fitoterapia; 2024 Mar; 173():105810. PubMed ID: 38163448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species.
    Butts A; Reitler P; Ge W; Fortwendel JR; Palmer GE
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-modified sordaricin derivatives: synthesis and antifungal activity.
    Regueiro-Ren A; Carroll TM; Chen Y; Matson JA; Huang S; Mazzucco CE; Stickle TM; Vyas DM; Balasubramanian BN
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3403-5. PubMed ID: 12419371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints].
    Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S
    Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
    Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
    Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biguanides enhance antifungal activity against Candida glabrata.
    Xu S; Feliu M; Lord AK; Lukason DP; Negoro PE; Khan NS; Dagher Z; Feldman MB; Reedy JL; Steiger SN; Tam JM; Soukas AA; Sykes DB; Mansour MK
    Virulence; 2018; 9(1):1150-1162. PubMed ID: 29962263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Polyphenolic Compounds against Candida glabrata.
    Salazar-Aranda R; Granados-Guzmán G; Pérez-Meseguer J; González GM; de Torres NW
    Molecules; 2015 Sep; 20(10):17903-12. PubMed ID: 26426003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mating genotypes and susceptibility profiles of clinical isolates of Candida glabrata from Turkey.
    Kaplan E; Aktaş D; Önder Ş; Metin B; Döğen A; Oz Y; Ilkit M
    Mycoses; 2019 Sep; 62(9):796-802. PubMed ID: 31134666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Eugenol Glucoside-based Derivative Shows Fungistatic and Fungicidal Activity against Opportunistic Candida glabrata.
    de Souza TB; Brito KM; Silva NC; Rocha RP; de Sousa GF; Duarte LP; Coelho LF; Dias AL; Veloso MP; Carvalho DT; Dias DF
    Chem Biol Drug Des; 2016 Jan; 87(1):83-90. PubMed ID: 26215123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.